Display options
Cite
Morrot A. The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host. Scientifica (Cairo). 2013;2013:965856doi: 10.1155/2013/965856.
Morrot, A. (2013). The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host. Scientifica, 2013965856. https://doi.org/10.1155/2013/965856
Morrot, Alexandre. "The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host." Scientifica vol. 2013 (2013): 965856. doi: https://doi.org/10.1155/2013/965856
Morrot A. The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host. Scientifica (Cairo). 2013;2013:965856. doi: 10.1155/2013/965856. Epub 2013 Dec 22. PMID: 24455435; PMCID: PMC3885277.
Copy Download .nbib Format: NLM
Share it on

Scientifica (Cairo). 2013;2013:965856. doi: 10.1155/2013/965856. Epub 2013 Dec 22.

The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host.

Scientifica

Alexandre Morrot

Affiliations

  1. Institute of Microbiology, Federal University of Rio de Janeiro, CCS, Sala D1-035, Avenida Carlos Chagas Filho 373, Cidade Universitária, Ilha do Fundão, 21.941-902 Rio de Janeiro, RJ, Brazil.

PMID: 24455435 PMCID: PMC3885277 DOI: 10.1155/2013/965856

Abstract

Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and is an important endemic infection in Latin America. Lately, it has also become a health concern in the United States and Europe. Most of the immunomodulatory mechanisms associated with this parasitic infection have been attributed to mucin-like molecules on the T. cruzi surface. Mucins are high molecular weight glycoproteins that are involved in regulating diverse cellular activities in both normal and pathological conditions. In Trypanosoma cruzi infection, the parasite-derived mucins are the main acceptors of sialic acid and it has been suggested that they play a role in various host-parasite interactions during the course of Chagas disease. Recently, we have presented evidence that sialylation of the mucins is required for the inhibitory effects on CD4(+) T cells. In what follows we propose that signaling via sialic acid-binding Ig-like lectin receptors for these highly sialylated structures on host cells contributes to the arrest of cell cycle progression in the G1 phase and may allow the parasite to modulate the immune system of the host.

References

  1. Adv Parasitol. 2011;76:129-52 - PubMed
  2. Trends Parasitol. 2005 May;21(5):237-43 - PubMed
  3. Clin Exp Immunol. 2000 Jul;121(1):112-9 - PubMed
  4. J Immunol. 2013 Jan 1;190(1):106-14 - PubMed
  5. Infect Immun. 1999 Jan;67(1):308-18 - PubMed
  6. PLoS Negl Trop Dis. 2009 Jul 07;3(7):e417 - PubMed
  7. J Biomed Biotechnol. 2001;1(1):11-17 - PubMed
  8. Eur J Immunol. 2003 Sep;33(9):2439-48 - PubMed
  9. Clin Microbiol Rev. 1999 Apr;12(2):210-23 - PubMed
  10. PLoS Negl Trop Dis. 2013;7(1):e1965 - PubMed
  11. Biochem J. 2001 Feb 1;353(Pt 3):483-92 - PubMed
  12. Int Immunol. 2004 Oct;16(10):1365-75 - PubMed
  13. Nat Rev Microbiol. 2006 Mar;4(3):229-36 - PubMed
  14. J Cell Sci. 2000 Apr;113 ( Pt 7):1299-307 - PubMed
  15. J Biol Chem. 2011 Mar 11;286(10):7797-7811 - PubMed
  16. J Immunol. 1995 Oct 15;155(8):3955-63 - PubMed
  17. J Leukoc Biol. 2004 Jun;75(6):951-61 - PubMed
  18. Clin Immunol Immunopathol. 1997 Feb;82(2):125-32 - PubMed
  19. Int Immunol. 2002 Oct;14(10):1135-44 - PubMed
  20. Annu Rev Immunol. 2012;30:357-92 - PubMed
  21. Lancet Infect Dis. 2001 Sep;1(2):92-100 - PubMed
  22. Eur J Immunol. 2006 Jun;36(6):1486-93 - PubMed
  23. PLoS One. 2013 Oct 28;8(10):e77568 - PubMed
  24. Immunol Lett. 1998 Sep;63(2):113-20 - PubMed
  25. Oncogene. 2005 Apr 18;24(17):2909-15 - PubMed
  26. Eur J Cell Biol. 2010 Jan;89(1):113-6 - PubMed
  27. Cell Microbiol. 2012 May;14(5):634-43 - PubMed
  28. Scand J Immunol. 2007 Aug-Sep;66(2-3):137-42 - PubMed
  29. J Allergy Clin Immunol. 2013 Apr;131(4):959-71 - PubMed
  30. Parasite Immunol. 1991 Jul;13(4):345-56 - PubMed
  31. J Virol. 2011 Oct;85(19):10300-9 - PubMed
  32. J Immunol. 2012 Dec 1;189(11):5119-28 - PubMed
  33. Carbohydr Res. 2011 Sep 6;346(12):1389-93 - PubMed
  34. Annu Rev Immunol. 2000;18:83-111 - PubMed
  35. Infect Immun. 2012 Jul;80(7):2258-64 - PubMed
  36. Front Immunol. 2012 Nov 28;3:361 - PubMed
  37. Mol Biochem Parasitol. 2002 Nov-Dec;125(1-2):91-101 - PubMed
  38. Curr Top Microbiol Immunol. 2005;296:89-123 - PubMed
  39. J Immunol. 2009 Jul 15;183(2):1245-52 - PubMed
  40. Braz J Med Biol Res. 2011 Feb;44(2):84-90 - PubMed
  41. J Immunol. 1998 Feb 1;160(3):1313-9 - PubMed
  42. Parasite Immunol. 2009 Nov;31(11):673-85 - PubMed
  43. Eur J Immunol. 2004 Apr;34(4):1175-84 - PubMed
  44. Proc Natl Acad Sci U S A. 1986 Sep;83(17):6593-7 - PubMed
  45. Trends Parasitol. 2002 Jun;18(6):262-5 - PubMed
  46. Circulation. 1985 Jun;71(6):1255-61 - PubMed
  47. Nat Rev Cardiol. 2012 Oct;9(10):576-89 - PubMed
  48. J Immunol. 2006 Oct 15;177(8):5024-31 - PubMed
  49. Infect Immun. 1999 Oct;67(10):5434-40 - PubMed
  50. Proc Natl Acad Sci U S A. 1981 Jan;78(1):602-5 - PubMed
  51. Cell Microbiol. 2002 Nov;4(11):701-11 - PubMed
  52. J Biol Chem. 1995 Oct 13;270(41):24146-9 - PubMed
  53. Annu Rev Microbiol. 1994;48:499-523 - PubMed
  54. Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12063-8 - PubMed
  55. Infect Agents Dis. 1992 Jun;1(3):136-45 - PubMed
  56. Scand J Immunol. 2013 Jul;78(1):1-7 - PubMed
  57. Cell Microbiol. 2009 Nov;11(11):1600-11 - PubMed
  58. J Immunol. 2008 Sep 1;181(5):3116-25 - PubMed
  59. Eur J Immunol. 1999 May;29(5):1684-91 - PubMed
  60. Trends Parasitol. 2010 Oct;26(10):499-505 - PubMed
  61. FEMS Microbiol Rev. 2012 May;36(3):734-47 - PubMed
  62. Pediatr Clin North Am. 2013 Apr;60(2):471-85 - PubMed
  63. J Infect Dis. 1992 Sep;166(3):598-603 - PubMed
  64. Cell. 1991 Jun 28;65(7):1117-25 - PubMed
  65. Curr Opin Immunol. 2010 Oct;22(5):566-74 - PubMed
  66. Nat Rev Immunol. 2009 Dec;9(12):833-44 - PubMed
  67. J Biol Chem. 1995 Mar 31;270(13):7241-50 - PubMed
  68. Infect Immun. 2004 Sep;72(9):5274-82 - PubMed
  69. Immunol Rev. 1989 Dec;112:183-207 - PubMed
  70. Biochem Biophys Res Commun. 2010 Nov 26;402(4):663-9 - PubMed
  71. Eur J Immunol. 2013 Sep;43(9):2295-304 - PubMed
  72. Trends Parasitol. 2002 Jun;18(6):272-8 - PubMed
  73. Nat Immunol. 2013 May;14(5):514-22 - PubMed
  74. Cancer Cell. 2012 Oct 16;22(4):452-65 - PubMed
  75. PLoS Negl Trop Dis. 2011 Aug;5(8):e1268 - PubMed
  76. Glycoconj J. 2013 Oct;30(7):659-66 - PubMed
  77. Nat Rev Immunol. 2007 Apr;7(4):255-66 - PubMed
  78. Int J Cell Biol. 2010;2010: - PubMed
  79. Acta Trop. 2002 Feb;81(2):123-32 - PubMed
  80. J Immunol. 1987 Oct 1;139(7):2452-7 - PubMed
  81. Clin Dev Immunol. 2010;2010:547179 - PubMed

Publication Types